Marshall Wace, LLP Vera Therapeutics, Inc. Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
A detailed history of Marshall Wace, LLP transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 583,725 shares of VERA stock, worth $21.6 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
583,725
Previous 524,578
11.28%
Holding current value
$21.6 Million
Previous $19 Million
35.91%
% of portfolio
0.03%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding VERA
# of Institutions
184Shares Held
55.2MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$160 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$146 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$124 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$110 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$103 Million11.68% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...